Home › Research › Treatments
Advances in Diagnostics and Treatments for Alzheimer's Disease
Sunderland A, Thatcher AL, Rackley EV, Kuruvilla T.. British journal of hospital medicine (London, England : 2005), 2025-12-19
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
The rising prevalence of Alzheimer's disease (AD) with an aging population poses significant societal and healthcare challenges, leading to growing interest in strategies for early diagnosis and disease modification. This review synthesizes key developments in the diagnostic and therapeutic landscape of AD for general hospital clinicians. Diagnostic advances include improving the detection of hallmark biomarkers-amyloid beta (Aβ) and phosphorylated tau (p-tau)-via neuroimaging modalities, cerebrospinal fluid (CSF) analysis, and increasingly accessible plasma-based assays. Disease-modifying therapies which target amyloid, including Lecanemab and Donanemab, offer promising avenues but require close clinical monitoring due to associated risks such as amyloid-related imaging abnormalities (ARIA). While the amyloid and tau hypotheses continue to underpin much of the pathophysiological understanding of AD, current models also recognise the role of additional mechanisms such as chronic neuroinflammation and oxidative stress, broadening the scope for therapeutic targets. Collectively, these diagnostic and therapeutic advances represent a significant shift in AD early identification and management, with implications for the individual patient and the healthcare system.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Sunderland, A., Thatcher, A. L., Rackley, E. V., & Kuruvilla, T. (2025). Advances in Diagnostics and Treatments for Alzheimer's Disease. British journal of hospital medicine (London, England : 2005). https://doi.org/10.12968/hmed.2025.0492
Vancouver
Sunderland A, Thatcher AL, Rackley EV, Kuruvilla T. Advances in Diagnostics and Treatments for Alzheimer's Disease. British journal of hospital medicine (London, England : 2005). 2025. doi:10.12968/hmed.2025.0492. PMID: 41443223.
BibTeX
@article{sunderland2025-41443223,
author = {Sunderland, A. and Thatcher, A. L. and Rackley, E. V. and Kuruvilla, T.},
title = {{Advances in Diagnostics and Treatments for Alzheimer's Disease}},
journal = {British journal of hospital medicine (London, England : 2005)},
year = {2025},
doi = {10.12968/hmed.2025.0492},
pmid = {41443223},
url = {https://doi.org/10.12968/hmed.2025.0492}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The rising prevalence of Alzheimer's disease (AD) with an aging population poses significant societal and healthcare challenges, leading to growing interest in strategies for early diagnosis and disease modification.
- Collectively, these diagnostic and therapeutic advances represent a significant shift in AD early identification and management, with implications for the individual patient and the healthcare system.
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Evidence strengthLow
How this study scored 41/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 24 of the 58 points we could judge it on, which is 41 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (British journal of hospital medicine (London, England : 2005)) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41443223) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 24 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 24 of the 58 points we could judge it on is 41 out of 100. |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Treatments from nearby years
Also tagged “advances”
6 studies in the library carry the topic tag “advances”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 6 tagged studies.